A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy
Pilot Study of Mobile Application Designed to Assist Patients Undergoing Radiation Therapy
3 other identifiers
interventional
20
1 country
1
Brief Summary
This clinical trial determines how well the oncpatient mobile application work in assisting patients undergoing radiation treatment. Radiation therapy can be complex. The technology, daily treatments, and possible side effects can be confusing to prevent and manage. Traditional radiation patient education includes a large amount of information, including details of treatment logistics, side effect prevention, and management. However, this information is not always readily accessible or memorable through the long course of therapy, and critical details can be missed. Oncpatient is a mobile application intended to be a more convenient and accessible form of patient education and guidance that is readily available to help patients and their caretakers navigate through radiation treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2021
CompletedFirst Posted
Study publicly available on registry
December 30, 2021
CompletedStudy Start
First participant enrolled
June 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
January 5, 2026
December 1, 2025
4 years
December 27, 2021
December 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Completion rate
The percent of patients who indicate in the survey that they were able to download the application and use it at least once during radiation will be defined as the completion rate.
Up to 1 year
Secondary Outcomes (3)
Patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments
Up to 1 year
Satisfaction with the mobile application and radiation treatment
Up to 1 year
Opinions on existing or new features for the mobile application to be given to future patients
Up to 1 year
Study Arms (1)
Supportive Care (oncpatient application, survey)
EXPERIMENTALPatients use the oncpatient mobile application over the course of radiation therapy. Patients also complete a survey on the final day of radiation treatment.
Interventions
Use oncpatient mobile application
Eligibility Criteria
You may qualify if:
- Age 18 and older.
- Can read and speak English and provide informed consent.
- Diagnosed with cancer, any stage, any disease site.
- Must be consented to undergo a course of radiotherapy, starting within one month. No limits on duration of radiation apply. Patients must be consented prior to initiating radiotherapy, however.
- Has regular access to a mobile device.
You may not qualify if:
- Less than 18 years old.
- Non-English speaking.
- Inability to operate a mobile device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
City of Hope Medical Center
Duarte, California, 91010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colton Ladbury
City of Hope Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2021
First Posted
December 30, 2021
Study Start
June 29, 2022
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
June 15, 2026
Last Updated
January 5, 2026
Record last verified: 2025-12